Press Release from Emulate


Twist Bioscience Launches Two SARS-CoV-2 Antibody Panels to Expedite Research for COVID-19

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Jul. 28, 2020-- Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced the availability of two new SARS-CoV-2 antibody panels designed for research use only.

Please see the full press release here:

Posted: 24-Sep-2020

United States
3475135304 Main website

Hosted By

The European Laboratory Research & Innovation Group Our Vision : To provide outstanding, leading edge knowledge to the life sciences community on an open access basis
Event Logo Find us on Facebook Follow us on Twitter

Get the App

Get this event information on your mobile by
going to the appstore or google play and search for 'elrig'
Eventflo Home
copyright ELRIG,, Labhoo Ltd 2003-2021